Martínez-Domínguez Samuel J, Laredo Viviana, García-Rayado Guillermo
Department of Gastroenterology, Lozano Blesa University Hospital, Zaragoza, Spain.
Aragón Health Research Institute (IIS Aragón), Zaragoza, Spain.
Front Nutr. 2024 Jul 10;11:1398147. doi: 10.3389/fnut.2024.1398147. eCollection 2024.
The aim of this systematic review was to assess the role of vitamin C in the prevention of pancreatic cancer (PC).
A comprehensive literature search was performed in PubMed, Embase and Web of Science up to August 2023, to identify randomized controlled trials (RCT), cohort studies and mendelian randomization studies based on prospective databases assessing the role of vitamin C in PC prevention.
A total of twelve studies including European and North-American participants were included: two RCT, three mendelian randomization (MR) studies and seven cohort studies. Both RCT showed high quality in Cochrane risk of bias tool. Only one cohort study had <7 points in Newcastle Ottawa Scale. Both RCT found no association between the intake of 500 mg/day of vitamin C and the incidence of PC. Only one prospective cohort study found an association between vitamin C serum levels and a lower incidence of PC. The remaining cohort studies and MR studies found no association between dietary/supplements intake of vitamin C or circulating vitamin C levels and the incidence of PC.
There is no supporting evidence that vitamin C prevents PC development. Future prospective quality studies including high-risk populations are needed.
本系统评价旨在评估维生素C在预防胰腺癌(PC)中的作用。
截至2023年8月,在PubMed、Embase和Web of Science中进行了全面的文献检索,以识别基于前瞻性数据库评估维生素C在预防PC中作用的随机对照试验(RCT)、队列研究和孟德尔随机化研究。
共纳入了12项包括欧洲和北美参与者的研究:2项RCT、3项孟德尔随机化(MR)研究和7项队列研究。两项RCT在Cochrane偏倚风险工具中显示出高质量。只有一项队列研究在纽卡斯尔渥太华量表中的得分<7分。两项RCT均未发现每天摄入500毫克维生素C与PC发病率之间存在关联。只有一项前瞻性队列研究发现维生素C血清水平与较低的PC发病率之间存在关联。其余队列研究和MR研究均未发现维生素C的饮食/补充剂摄入量或循环维生素C水平与PC发病率之间存在关联。
没有支持性证据表明维生素C可预防PC的发生。未来需要开展包括高危人群在内的前瞻性高质量研究。